Androstenedione
is a steroid hormone, described as a ‘pro-hormone’, produced
mainly in the testes in men and in the ovaries in women, which is
used to increase the production of hormones testosterone and
estrogen. Androstenedione is taken orally specifically to increase
the testosterone level. By boosting testosterone levels,
androstenedione is believed to improve the athletic performance,
enhance recovery and growth from exercise, increase energy, keep red
blood cells healthy, and increase the sexual desire and performance.
Androstenedione
is taken orally in a contraceptive pills or capsules and is available
in a spray form that is administered under the tongue for instant
results. Common side effects of androstenedione in men include low
sperm production, painful and prolonged erections, breast
development, heart diseases, behavioral changes, and others. In
women, side effects such as abnormal menstrual periods and depression
are observed. Androstenedione can increase chances of breast,
prostate, or pancreas cancer and it is poisonous to liver. The
control of androstenedione is very complex due to its secretion from
number of other glands and its rapid conversion to other hormones.
The usual dosage of androstenedione is 50-100 milligrams in pill form
twice daily.
Get
The Inside Scoop Of The Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2634
Global
Androstenedione Market- Dynamics
Increase
in adoption of androstenedione as a dietary supplement is major
factor driving growth of the global androstenedione market. Young
people and athletes frequently consume androstenedione to strengthen
the body. Moreover, rising prevalence of various infectious
inflammation diseases and arthritis are major factors expected to
augment growth of the global androstenedione market in the near
future. According to Arthritis Foundation, in 2015, prevalence of
osteoarthritis in the U.S. was estimated at 30.8 million in adults
and 14 million individuals in the U.S. have symptomatic knee
arthritis. This is expected to increase adoption of androstenedione.
However,
stringent government regulations is major factor restraining growth
of the global androstenedione market. For instance, androstenedione
is banned by the World Anti-Doping Agency (WADA) and International
Olympic Committee (IOC), under the category of androgenic anabolic
steroids. However, adverse effects of androstenedione include
sustained increase in serum estrogen and increase in serum
luteinizing hormone, lean muscle mass, and bone growth problem in
children, thus restraining growth of the global androstenedine
market. Furthermore, pregnant women are warned from using these pills
as they are linked with higher risks of labor and cause of
miscarriage.
Global
Androstenedione Market- Regional Dynamics
Regional
segmentation of the global androstenedione market by Coherent Market
Insights comprises North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America, especially the U.S.,
is expected to hold dominant position in the global androstenedione
market over the forecast period. For instance, according to
international perspectives on sexual and reproductive health
research, in 2015, North America, fertility control rate is decreased
by 0.3%, thereby augmenting the global androstenedione market growth.
In 2015, an estimated 1.3% adults (3 million) are reported being
diagnosed by inflammatory bowel disease.
Global
Androstenedione Market- Competitive Analysis
Market
players are engaged in developing new products to maintain leading
position in global androstenedione market. Androstenedione is
marketed primarily to athletes as a potential anabolic agent and is
also claimed to have beneficial effects on general well-being,
libido, and quality of life.
Some
of the key players operating in the global androstenedione market
include BIOVET, Indo Phyto Chemicals, Goto Pharmaceutical, Kaizon,
Jiufu, Darui, Yongning Pharma, Dahua Pharmaceutical, Sito Bio,
Dongyao Pharmaceutical, and Huazong Pharmaceuticals.
Global
Androstenedione Market- Market Taxonomy
On
the basis product type, global androstenedione market is segmented
into:
-
Androstenedione (4-AD)
-
Androstadienedione ( ADD)
On
the basis of application, global androstenedione market is segmented
into:
-
Infectious Inflammation
-
Arthritis
-
Fertility Control
-
Others
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/ongoing-insight/androstenedione-market-2634
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment